title: Superovulation in vesper mice, Calomys laucha--an important biomedical model for hantavirus and arenavirus (Rodentia-Sigmodontinae).
abstract: Sigmodontine rodents are poorly studied and have not received much attention as a reproductive model. Renewed interest in the South American rodents has been stimulated by their link to endemic diseases that are transmitted to man. Calomys laucha acts as a reservoir of two dangerous viruses: an arenavirus named 'Junin virus', the aetiological agent of Argentinian haemorrhagic fever, and the hantavirus, both of which constitute serious sanitary problems. The aim of this study was to establish suitable conditions to superovulate the vesper mouse, Calomys laucha. We examined the hormonal doses, the time interval between hormones, the time-course of ovulation, and the effect of female age on the response to exogenous hormone administration. Female mice were injected with 5-5, 8-8 or 12-15 IU of PMSG/hCG, 48 h apart, at different age intervals (from 30 to > 120 days old). The best superovulation rate was obtained with 8-8 IU PMSG/hCG. Ovulation started about 10 h post-hCG and was completed during the next 4-5 h, and was achieved irrespectively from the oestrus cycle stage. The number of oocytes was influenced by the age of the females. The youngest females had only a superovulatory response. Females older than 61 days showed both ovulatory and superovulatory responses, although 91-120-day-old females had a high ovulatory response. Most of the oocytes (96.5%) recovered were morphologically normal. The genus Calomys constitutes a reproductive model completely different from conventional laboratory rodents.
authors.affiliation: Centro de Estudios Farmacológicos y Botánicos (CEFYBO-CONICET), Capital Federal, Argentina. lasserre@dna.uba.ar
authors.forename: A
authors.initials: A
authors.lastname: Lasserre
authors.forename: E
authors.initials: E
authors.lastname: Cebral
authors.forename: A D
authors.initials: AD
authors.lastname: Vitullo
mesh_terms: D000375:Aging / Q000502:physiology; D000818:Animals; D001117:Arenaviridae Infections / Q000662:veterinary* / Q000821:virology; D006063:Chorionic Gonadotropin / Q000494:pharmacology; D004195:Disease Models, Animal; D004197:Disease Reservoirs; D005260:Female; D006064:Gonadotropins, Equine / Q000494:pharmacology; D018778:Hantavirus Infections / Q000662:veterinary* / Q000821:virology; D051379:Mice; D009865:Oocytes / Q000187:drug effects / Q000473:pathology; D010312:Parthenogenesis; D012098:Reproduction / Q000187:drug effects / Q000502:physiology; D012377:Rodentia / Q000502:physiology* / Q000821:virology; D013480:Superovulation / Q000187:drug effects / Q000502:physiology*; D013997:Time Factors
chemical_list: D006063:Chorionic Gonadotropin; D006064:Gonadotropins, Equine